Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel, Temozolomide and Bevacizumab in Metastatic Melanoma With Brain Metastases
NCT02065466Phase 2Withdrawn
- Sponsor
- University of Arizona
- Start
- Jul 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, temozolomide, bevacizumab in melanoma, sponsored by University of Arizona. Planned start Jul 2014; status: withdrawn.
02
Drugs
paclitaxeltemozolomidebevacizumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02065466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065466.